The past few years, the four biggest tobacco companies (Philip Morris International/Altria, British American Tobacco, Japan Tobacco International and Imperial Brands) have all invested in medical products. Meanwhile, they continue to sell tobacco on a large scale in Asia and Africa, which are still growth markets for them.
Research by The Investigative Desk and the Dutch Journal of Medicine (NTvG) shows that Big Tobacco focuses mainly on remedies for conditions caused or aggravated by smoking, such as inhalers for patients with asthma and COPD, technology for home monitoring of diabetes and heart disease, and anti-addiction treatments.
The tobacco industry makes its customers ‘pass the pay desk twice’: once for the cigarettes they smoke, and again for anti-addiction remedies. Tobacco companies thus unethically create their own outlet.
US chemicals multinational Chemours in Dordrecht (the Netherlands) makes hundreds of millions in profits and is polluting the environment with toxic s
While the world is considering phasing out fossil fuels, Guyana (South-America) is busy with oil drilling. The oil company ExxonMobil extracts reserve
The tobacco industry is earning double from patients who have become ill from smoking through billions in medical investments. Outrage among doctors i